Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis

Saved in:
Bibliographic Details
Published in:Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 1996-03, Vol.60 (3), p.348-349
Main Authors: Mase, G, Zorzon, M, Biasutti, E, Vitrani, B, Cazzato, G, Urban, F, Frezza, M
Format: Article
Language:English
Subjects:
Chronic Disease
Genetic Predisposition to Disease
Hepatitis C - therapy
Humans
Interferon alpha-2
Interferon-alpha - adverse effects
Interferon-alpha - therapeutic use
Male
Middle Aged
Myasthenia Gravis - chemically induced
Myasthenia Gravis - genetics
Recombinant Proteins
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0022-3050
1468-330X
DOI:10.1136/jnnp.60.3.348-a